Cizzle is a medical device company developing a companion diagnostic biomarker for the early detection of lung cancer. The blood test will be used alongside a positive chest scan to confirm presence of lung cancer and reduce the high rate of false positives.
If you'd like to be introduced to the team at Cizzle Biotechnology, get in touch.
Request a meeting
